Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 2c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Zimmer Biomet (ZBH) PT Lowered to $130 at Stifel
August 7, 2024 2:03 PM EDTStifel analyst Rick Wise lowered the price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $135.00) while maintaining a Buy rating.
The analyst comments "We left Zimmer's 2Q24 earnings call better-appreciating the many fundamental positives and sales growth drivers. We were reminded that over... More
